GB1601658A - Composition for chewing gums - Google Patents
Composition for chewing gums Download PDFInfo
- Publication number
- GB1601658A GB1601658A GB12878/78A GB1287878A GB1601658A GB 1601658 A GB1601658 A GB 1601658A GB 12878/78 A GB12878/78 A GB 12878/78A GB 1287878 A GB1287878 A GB 1287878A GB 1601658 A GB1601658 A GB 1601658A
- Authority
- GB
- United Kingdom
- Prior art keywords
- xylitol
- sorbitol
- sorbose
- composition
- fluorine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title claims description 44
- 235000015218 chewing gum Nutrition 0.000 title claims description 33
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 50
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 50
- 229960002675 xylitol Drugs 0.000 claims description 50
- 239000000811 xylitol Substances 0.000 claims description 50
- 235000010447 xylitol Nutrition 0.000 claims description 50
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 50
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 33
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 31
- 239000011737 fluorine Substances 0.000 claims description 31
- 229910052731 fluorine Inorganic materials 0.000 claims description 31
- 239000000600 sorbitol Substances 0.000 claims description 31
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 claims description 27
- 229940112822 chewing gum Drugs 0.000 claims description 27
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 24
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 16
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 13
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 239000011775 sodium fluoride Substances 0.000 claims description 8
- 235000013024 sodium fluoride Nutrition 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 150000002221 fluorine Chemical class 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 4
- 239000005662 Paraffin oil Substances 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- BJHIKXHVCXFQLS-OTWZMJIISA-N keto-L-sorbose Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-OTWZMJIISA-N 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 description 18
- 230000001013 cariogenic effect Effects 0.000 description 10
- 208000002064 Dental Plaque Diseases 0.000 description 8
- 210000003298 dental enamel Anatomy 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 210000003296 saliva Anatomy 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000013681 dietary sucrose Nutrition 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229960004793 sucrose Drugs 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 150000008131 glucosides Chemical class 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000000248 cariostatic effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000000540 preeruptive effect Effects 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 108010042889 Inulosucrase Proteins 0.000 description 1
- 244000019194 Sorbus aucuparia Species 0.000 description 1
- 235000009790 Sorbus aucuparia Nutrition 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 241001134658 Streptococcus mitis Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 241000194024 Streptococcus salivarius Species 0.000 description 1
- 230000002053 acidogenic effect Effects 0.000 description 1
- 230000000170 anti-cariogenic effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 229940077441 fluorapatite Drugs 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
- 230000018984 mastication Effects 0.000 description 1
- 238000010077 mastication Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
Description
(54) NEW COMPOSITION FOR CHEWING GUMS
(71) I, JEAN-JACQUES GOUPIL, of 30 Avenue du President Wilson, 94239 Cachan,
France, a French citizen do hereby declare the invention, for which I pray that a patent may be granted to me, and the method by which it is to be performed, to be particularly described in and by the following statement:
The present invention relates to a manufacturing process for producing chewing gums and to the resulting compositions.
Fluorine, which is vital to the mineral internal build-up of teeth in the pre-eruptive phase is also fundamental to their topical protection as early as the post-eruptive phase, by reinforcing the enamel and making it less vulnerable to attack by cariogenic acids whose production fluorine contributes to inhibit or to slow down by direct action on the bacterial enzymes and the microbial bodies of dental plaque.
The cariostatic action of fluorine is now largely demonstrated and admitted, be it in the case of ingestion (internal route) or local application (topical route). This effect is exerted on the tooth through a crystalline chemical action and on saliva and dental plaque by biochemical action.
Fluorine acts on the tooth in a pre-eruptive phase or a post-eruptive phase by reinforcing its mineral structure:
(a) by the formation of fluorapatite; and (b) by reinforcing the "crystallinity" of the calcium phosphates and their precipitation in the most stable form, namely Hydroxyapatite.
This action gives to the enamel:
(a) a greater resistance to external agents, leading to a better mineral build-up; and
(b) less solubility in the cariogenic acids.
On the other hand, fluorine, due to its anti-enzymatic properties acts by blocking or by reducing the saliva enzymes and, as a consequence, by inhibiting or limiting the formation of cariogenic acids which are highly destructive of the enamel.
Dental plaque or bacterial plaque is a deposit which forms at the base of teeth adjacent to the gums and which, in spite of daily hygiene, is very quickly reformed between two brushings of the teeth. This sticky coating is formed of modified saliva proteins which become insoluble, or mucopolysaccharides and uncountable microbial bodies.
As recently shown, if accumulated in plaque 95% in combined form (in particular inside the microbial bodies) and not ionized, fluorine can play a full role as an enzyme inhibitor and in preventing the formation of cariogenic acids.
A further feature of the plaque against which the fluorine acts as its ability to synthesize, through the action of the bacterial enzymes (glucosyltransferases - fructosyltransferases), reserve polysaccharides from ingested sugars, glucose or dextrose (dextran), levulose (levan), both originating from glucidic hydrolysis of saccharose, recognized as being the most cariogenic sugar (under certain conditions of use : division and repetition of intakes, sticky sweets, night sweets, and so on).
This capacity of the enzymes to form sugar reserves, which are thereafter progressively degraded, results in maintaining a local acidity the prolonged action of which results in a progressive dissolution of the enamel mineral salts (pH < 5.5).
Fluorine prevents the synthesis of such poly-saccharides at concentrations of 10 ppm.
Moreover, the growth and metabolism of the acidogenic germs of dental plaque are very strongly inhibited by fluorine used locally. This action has been known for a long time and has to be added to what has been said about its anti-enzymatic action.
This bacteriostatic action requires local concentrations of fluorine of the order of 10 to 20 ppm.
In conclusion, the biochemical activity of fluorine is exerted in the post-eruptive phase, directly and locally on the saliva and the dental plaque due to the following properties of the fluorine:
(a) antienzymatic
(b) bacteriostatic, and this due to its ability to accumulate in the plaque where it may reach efficient rates, particularly by concentrating in the microbial bodies themselves.
This double feature results in an important reduction, and even in inhibition, of the local cariogenic acidity.
The various means for using fluorine are via the internal route and the local route.
It has been demonstrated that, for an equal concentration of fluorine, a sweet tablet before being swallowed has an efficiency substantially greater than the same tablet directly swallowed.
This result is explained by the fact that, in the first case, the fluorine concentrating in the saliva may, due to its affinity for the mineral salts of the enamel and the dental plaque, quickly fix on the latter and protect the tooth through a local action quicker and better than by the internal route only.
This dispensing mode offers therefore the advantage of associating both cario-preventive action possibilities of fluorine : the internal route and the topical route, the latter appearing now to be as important, and even more important, than the general route as early as the post-eruptive phase.
In this spirit, it has been thought quite natural to use carriers which lead to maintaining in the mouth prolongated contact of the active element before swallowing. Chewing gum has proved to be, in particular for the child and the adolescent, the ideal support for this type of fluorine dispensation. In fact, it provides in a simple and pleasant way, through the mechanical action of mastication, an easy penetration of the fluorine into the enamel by direct contact.
However, whereas the desired aim is the prevention of dental decay, the usual composition of any chewing gum is based on glucosides (saccharose, glucose etc.) which are strongly cariogenic.
There is, therefore, a fundamental anomaly which has led to devising of a rational formulation capable of being anti-cariogenic by its active principle : the fluorine, and acariogenic by its excipient.
The object of the invention is therefore twofold:
(a) the incorporation, at a convenient dosage, of fluorine, which is the cariostatic principle in chewing gum;
(b) the replacement of the usual cariogenic constituents of said gum by products having the same sweetening properties and, in particular, a sweetening power free from cariogenicity.
The choice has been made from three natural sweetening substances or edulcorants:
(i) Xylitol: of formula C5 H12 O (molecular weight 152.15), a penitol derived from xylose, a sugar existing in many fruits, cereals and vegetables;
(ii) L-sorbose: of formula C6 H12 O6 (molecular weight 180), a Retohexose existing in the natural state in rowan berries.
(iii) D-sorbitol: of formula C6 H14 O6 (molecular weight 182) existing naturally in numerous berries.
These saccharose substitutes show fundamental differences from the glucosides habitually used for the manufacture of chewing gums, as well as regarding their biological behaviour relative to saliva and dental plaque enzymes as cariogenic microorganisms of the oral cavity, e.g. Streptococcus mutans, mitis, salivarius, lactis and san gu is, and Actynomyces viscosus, with the result that none of them is used or fermented by these bacterial organisms or their enzymes.
As it is known that the latter are indispensable for building-up dental plaque, for its growth and its metabolic activities responsible for the decay process from a bio-chemical viewpoint, in particular by the enzymatic degradation of the glucosides and the sweet reserves of food origin leading to the production of cariogenic acids which are highly demineralizing for the enamel, one can only stress the obvious interest of such a formula associating xylitol, sorbose or sorbitol, instead of the sugar (saccharose) and glucose which are currently used.
According to the invention, I provide a process for preparing a chewing gum composition in which the only sweetening constituents incorporated therein are selected from xylitol,
L-sorbose and D-sorbitol, and mixtures thereof. and in which a component containing ionized fluorine in the form of fluorine soluble in water at a convenient dosage is also incorporated, the chewing gum base being kept free of any alkaline-earth metals in order to avoid precipitation of the fluorine ion in the state of an insoluble salt, and therefore inactive. Apart from the process, what is claimed as being part of the invention is the chewing gum composition produced by means of the process just described.
According to a first aspect of the invention, therefore, I provide a composition for chewing gum, characterised in that it contains a chewing gum base free of any alkaline-earth metals, a fluorine-containing salt soluble in water, and xylitol.
According to a second aspect of the invention, I provide a process for the preparation of a chewing gum composition wherein there is incorporated into a chewing gum base free of any alkaline-earth metals, after slow mixing at 65 , a fluorine salt soluble in water, xylitol and l-sorbose.
According to a third aspect of the invention, I provide a process for preparing a chewing gum composition wherein there is incorporated into a chewing gum base free of any alkaline-earth metals, after slow mixing at 650, a fluorine salt soluble in water, xylitol and sorbitol.
Any formulation-component for a chewing gum according to the invention will clearly have to be free from elements or chemical components capable of producing insoluble fluorides. The most important representatives of these elements are the alkaline-earth metals, that is mainly the calcium ion.
There are now given, as examples, a few formulations according to the invention:
A B C D
Na fluoride 0,007143 g 0,01000 g 0,01580 g 0,02212 g
Gum base 20.0 g 30.0 g 20.0 g 30.0 g
Xylitol 10.0 g 53.0 g 68.0 g 10.0 g
L-Sorbose 68.0 g 10.0 g 10.0 g 53.0 g
Paraffin oil 0.1 g 0.5 g 0.1 g 5.0 g
Glycerin 1.0 g 5.0 g 1.0 g 5.0 g
Aroma qs qs qs qs
Formulations A and B correspond to an intake in the tablet form of:
Sodium fluoride 0.250 mg(that is 0.113 mg F-)
Formula A : tablet of 3.50 g
Formula B : tablet of 2.50 g
Formulas C and D correspond to an intake in the tablet form of:
Sodium fluoride... ....0.553 mg (that is 0.250 mg F-)
Formula C : tablet of 3.50 g
Formula D : tablet of 2.50 g
E F G
Na fluoride 0.000250 g 0.000250 g 0.000553 g
Xylitol 0.170 g 0.867 g 1.530 g
Sorbitol 1.530 g 0.833 g 0.170 g
Aromatized gum base sufficient for (s.f.)2.50 g (s.f.)2.50 g (s.f.)2.50 g
I now give an example of a preparation process according to the invention.
In a Werner type mixer, in a water bath heated to a temperature which does not exceed 65 , there is introduced, under slow mixing, the gum base previously finely divided. When the latter is sufficiently softened and homogenous, paraffin oil or glycerin, or both, are added, and a part of Sorbose, or of Sorbitol, previously sieved. One waits a few minutes so that the mixture is correct, the heating is stopped and the remainder of the powders, sorbitol or sorbose and xylitol, also sieved, is progressively incorporated as well as the sodium fluoride.
The perfume is then added at the end of the operation together with a sufficient quantity of Sorbose or Sorbitol set aside. The mixture is stirred to complete homogeneity.
The paste is then treated to be transformed into tablets and packed.
The xylitol and sorbose contents, or the xylitol and sorbitol contents of the compositions for chewing gums of the present invention vary between 45% and 90% by weight.
The weight ratio of the xylitol on the one hand to the sorbose or the sorbitol on the other hand is comprised within the range of from 1 : 10 to 10 : 1, inclusive.
The concentration in fluorine per tablet, whatever its final weight, that is by unit of intake, may vary but within the fixed limits of 0.250 mg to 0.553 mg for the sodium fluoride, that is 0.113 mg to 0.250 mg for the fluorine component. On the other hand, the proportion of xylitol and sorbose, or of xylitol and sorbitol may vary, as a function of the final weight of the tablet and the composition of the excipient, within wide limits which may be for instance of 0.250 to 2.40 g.
WHAT I CLAIM IS:
1. A composition for chewing gum, characterised in that it contains a chewing gum base free of any alkaline-earth metals, a fluorine-containing salt soluble in water, and xylitol.
2. A composition according to claim 1, characterised in that it contains xylitol mixed with sorbose.
3. A composition according to claim 1, characterised in that it contains xylitol mixed with sorbitol.
4. A composition according to claim 2 or 3, characterised in that the xylitol, or the xylitol plus sorbose, or the xylitol plus sorbitol, content is between 45% and 90% by weight, based on the total composition.
5. A composition according to claim 4, wherein the weight ratio of the xylitol on the one hand to the sorbose or the sorbitol on the other hand is within the range of from 1:10 to 10:1.
6. A composition according to any one of the preceding claims, characterised in that it is presented in the form of tablets the fluorine content of each of which is between 0.113 mg and 0.250 mg, and the xylitol plus sorbose or xylitol plus sorbitol, content of which is between 0.250 g and 2.40 g.
7. A chewing gum tablet characterised in that it contains 0.000250 g of sodium fluoride, 0.867 g of xylitol, 0.883 g of sorbitol and an aromatized gum free of alkaline-earth metals in a quantity sufficient for a total weight of 2.50 g.
8. A process for the preparation of a chewing gum composition wherein there is incorporated into a chewing gum base free of any alkaline-earth metals, after slow mixing at 65 , a fluorine salt soluble in water, xylitol and l-sorbose.
9. A process for preparing a chewing gum composition wherein there is incorporated into a chewing gum base free of any alkaline-earth metals, after slow mixing at 650, a fluorine salt soluble in water, xylitol and sorbitol.
10. A process according to claim 8 or 9, wherein there is introduced into the composition between 45% and 90% by weight, based on the total composition, of xylitol plus sorbose or xylitol plus sorbitol.
**WARNING** end of DESC field may overlap start of CLMS **.
Claims (13)
1. A composition for chewing gum, characterised in that it contains a chewing gum base free of any alkaline-earth metals, a fluorine-containing salt soluble in water, and xylitol.
2. A composition according to claim 1, characterised in that it contains xylitol mixed with sorbose.
3. A composition according to claim 1, characterised in that it contains xylitol mixed with sorbitol.
4. A composition according to claim 2 or 3, characterised in that the xylitol, or the xylitol plus sorbose, or the xylitol plus sorbitol, content is between 45% and 90% by weight, based on the total composition.
5. A composition according to claim 4, wherein the weight ratio of the xylitol on the one hand to the sorbose or the sorbitol on the other hand is within the range of from 1:10 to 10:1.
6. A composition according to any one of the preceding claims, characterised in that it is presented in the form of tablets the fluorine content of each of which is between 0.113 mg and 0.250 mg, and the xylitol plus sorbose or xylitol plus sorbitol, content of which is between 0.250 g and 2.40 g.
7. A chewing gum tablet characterised in that it contains 0.000250 g of sodium fluoride, 0.867 g of xylitol, 0.883 g of sorbitol and an aromatized gum free of alkaline-earth metals in a quantity sufficient for a total weight of 2.50 g.
8. A process for the preparation of a chewing gum composition wherein there is incorporated into a chewing gum base free of any alkaline-earth metals, after slow mixing at 65 , a fluorine salt soluble in water, xylitol and l-sorbose.
9. A process for preparing a chewing gum composition wherein there is incorporated into a chewing gum base free of any alkaline-earth metals, after slow mixing at 650, a fluorine salt soluble in water, xylitol and sorbitol.
10. A process according to claim 8 or 9, wherein there is introduced into the composition between 45% and 90% by weight, based on the total composition, of xylitol plus sorbose or xylitol plus sorbitol.
11. A process according to any of claims 8, 9 and 10, wherein the weight ratio of the
xylitol on the one hand, to the sorbose or sorbitol on the other hand is within the range of from 1:10 to 10:1.
12. A composition according to claim 1, substantially as herein described with reference to any of the specific examples.
13. A process according to claim 8 or 9, substantially as herein described with reference to any of the specific examples.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7710051A FR2386308A1 (en) | 1977-04-04 | 1977-04-04 | PROCESS FOR PREPARING A CHEWING GUM THAT IS NON-CARIOGENIC AND CONTAINING FLUORINE, AND THE RESULTING PRODUCTS |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1601658A true GB1601658A (en) | 1981-11-04 |
Family
ID=9188964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB12878/78A Expired GB1601658A (en) | 1977-04-04 | 1978-04-03 | Composition for chewing gums |
Country Status (10)
Country | Link |
---|---|
BE (1) | BE865617A (en) |
DE (1) | DE2814316A1 (en) |
ES (1) | ES469251A1 (en) |
FR (1) | FR2386308A1 (en) |
GB (1) | GB1601658A (en) |
GR (1) | GR62854B (en) |
IT (1) | IT1093560B (en) |
LU (1) | LU79349A1 (en) |
OA (1) | OA08227A (en) |
ZA (1) | ZA781902B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0308317A1 (en) * | 1987-09-14 | 1989-03-22 | Sanofi | Chewable anorectic composition and process to prepare it |
ES2078186B1 (en) * | 1994-05-10 | 1996-07-16 | Cinfa S A Lab | CHEWING GUM AND ITS MANUFACTURING PROCEDURE. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2627493A (en) * | 1949-02-05 | 1953-02-03 | Wallace & Tiernan Inc | Fluorine chewing gum process |
FR2101009A1 (en) * | 1970-08-06 | 1972-03-31 | Audoire Pierre | Fluorine-contg chewing gum - for prevention of dental caries |
US3899593A (en) * | 1970-12-28 | 1975-08-12 | Gen Foods Corp | Xylitol chewing gum |
-
1977
- 1977-04-04 FR FR7710051A patent/FR2386308A1/en active Granted
-
1978
- 1978-03-28 GR GR55814A patent/GR62854B/en unknown
- 1978-03-31 LU LU79349A patent/LU79349A1/en unknown
- 1978-04-01 OA OA56458A patent/OA08227A/en unknown
- 1978-04-03 BE BE2056835A patent/BE865617A/en not_active IP Right Cessation
- 1978-04-03 GB GB12878/78A patent/GB1601658A/en not_active Expired
- 1978-04-03 DE DE19782814316 patent/DE2814316A1/en active Granted
- 1978-04-03 ES ES469251A patent/ES469251A1/en not_active Expired
- 1978-04-04 IT IT21968/78A patent/IT1093560B/en active
- 1978-04-04 ZA ZA00781902A patent/ZA781902B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE2814316C2 (en) | 1988-08-11 |
ES469251A1 (en) | 1978-11-16 |
LU79349A1 (en) | 1978-07-13 |
IT7821968A0 (en) | 1978-04-04 |
OA08227A (en) | 1987-10-30 |
DE2814316A1 (en) | 1978-10-05 |
GR62854B (en) | 1979-06-20 |
IT1093560B (en) | 1985-07-19 |
FR2386308A1 (en) | 1978-11-03 |
ZA781902B (en) | 1979-03-28 |
FR2386308B1 (en) | 1980-11-28 |
BE865617A (en) | 1978-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101290608B1 (en) | Noncarious material and anticarious agent containing rare sugar | |
AU719465B2 (en) | Anti-caries oral compositions | |
Peldyak et al. | Xylitol for caries prevention. | |
EP0009325A1 (en) | Erythritol cointaining anti-caries compositions | |
Imfeld | Efficacy of sweeteners and sugar substitutes in caries prevention | |
JP3689803B2 (en) | Tooth enamel remineralization accelerator, oral composition and food and drink | |
CN1201720C (en) | Oral care chewing gums and confections | |
JP3689802B2 (en) | Tooth enamel remineralization accelerator, oral composition and food and drink | |
US4508713A (en) | Method of reducing dental caries | |
US4255414A (en) | Edible or oral compositions | |
US4389394A (en) | Methods for reducing dental caries | |
US4284650A (en) | Composition for chewing gums | |
JPH0360802B2 (en) | ||
JPH0234322B2 (en) | ||
US4457921A (en) | Method of reducing dental caries | |
US4374122A (en) | Method of reducing dental caries | |
JP2002029952A (en) | Composition for dentifrice | |
Bowen et al. | Dental caries: Dietary and microbiology factors | |
WO2006123430A1 (en) | Dental enamel recalcification accelerator and containing the same, oral composition and food or beverage | |
CA2111973A1 (en) | Non-cariogenic sugar, confectionery and chocolate compositions | |
Kamasaka et al. | Production and application of phosphoryl oligosaccharides prepared from potato starch | |
GB1601658A (en) | Composition for chewing gums | |
JP4763441B2 (en) | Plaque formation inhibitor and oral composition and food containing the same | |
CN115177543B (en) | Antibacterial caries preventing composition containing L-lactate, oral care product and preparation method and application thereof | |
JPS625122B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PE20 | Patent expired after termination of 20 years |
Effective date: 19980402 |